Saving money is wise, but investing is profitable
In accordance with the legislation of the Czech Republic, the Company provides services only to qualified investors!
Vaxcyte Incorporated (PCVX) Financial results for the second quarter of 2020
Net loss per share – US$1.72.
Cash and cash equivalents were $410.0 million as of June 30, 2010, compared to $59.0 million as of December 31, 2019.
Заполните форму и наш специалист свяжется с вами в ближайшее время для уточнения деталей
Загрузка...